Bioavailability evidence

Peptide

ATLPC0015302

Measured material

Specific molecular form

Endpoint

Bioavailability

ADMET domain

Exposure / Absorption

Value

Observation

LINZESS is minimally absorbed with negligible systemic availability following oral administration.

Evidence role

Reported: reviewed reported observation that should not be pooled as a comparable value yet

Assay / model

human

Condition

Route: oral · Linaclotide · 09beda19-56d6-4a56-afdc-9a77b70b2ef3 · bioavailability negligible systemic availability text · LINZESS is minimally absorbed with negligible systemic availability fo...

Scientific source

DailyMed

Open source

Bioavailability evidence

Developability

Resources

Measurement